Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 4Completed 4Active not recruiting 3Unknown 2Withdrawn 1Terminated 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Tumor-Agnostic 1

Conditions

Neoplasms 1Glioma 1Brain Neoplasms 1

Interventions

pembrolizumab 438Carboplatin 321Nivolumab 293Cyclophosphamide 285Specimen Handling 257Paclitaxel 249Magnetic Resonance Spectroscopy 249Cisplatin 248Radiotherapy 218Dexamethasone 183Gemcitabine 177Biopsy 177durvalumab 169atezolizumab 149Doxorubicin 140Rituximab 138Lenalidomide 135Docetaxel 131Ipilimumab 130Bevacizumab 128Radiation 121Capecitabine 117Etoposide 116Oxaliplatin 114Fluorouracil 110Pemetrexed 109Radiosurgery 108fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Transcranial Magnetic Stimulation × Clear all
NCT03606161 2026-02-19

Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors

M.D. Anderson Cancer Center

Phase NA Active not recruiting
32 enrolled
CNS

Brain Neoplasms

NCT07285525 2025-12-16

Accelerating Motor Recovery in Glioma Patients Using Postoperative nrTMS

Beijing Neurosurgical Institute

Phase NA Active not recruiting
43 enrolled
CNS

Glioma

NCT03219502 2025-10-14

rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy

M.D. Anderson Cancer Center

Phase NA Active not recruiting
56 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡